ReviewComputational and structural biotechnology journal2024

A sustainable balance between innovation and risk: How the "right to science" affects China's medical biotechnology regulatory policy.

Yiping Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.